Unveiling the Intricate Relationship Between Glutamate and GLP-1: A Comprehensive Review


Glucagon‐like‐peptide‐1 (GLP‐1) derived from gut enteroendocrine cells and a discrete population of neurons in the caudal medulla acts through humoral and neural pathways to regulate satiety, gastric motility and pancreatic endocrine function. These ...
Apr 15, 2024GLP-1exerts neurostimulatory and neuromodulatory effects, regulating the release of several neurotransmitters, such as serotonin, dopamine, gamma-aminobutyric acid, andglutamate, which mediate (in part) important neurophysiological mechanisms linked to depression-related behaviors and those associated with other psychiatric disorders (54).
Glucagon-like peptide-1 (GLP-1) is mainly secreted by preproglucagon neurons; it plays important roles in modulating neuronal activity and synaptic transmission through its receptors.
Oct 1, 2024The caveat for exogenousGLP-1to function as an appetite suppressant is the requirement of a supraphysiological dose with exponentially greater folds in concentration and duration compared to endogenousGLP-1(Figure1). Functioning as an incretin hormone,GLP-1plays a key role in maintaining blood glucose homeostasis by increasing postprandial insulin secretion and reducing glucagon ...
Sep 1, 2025GLP-1receptor agonists (GLP-1RAs), initially approved for diabetes and obesity, are now under investigation for neuroprotective effects in a range of neurological disorders. These agents, whose receptors are widely expressed in brain regions involved in cognition and metabolism, modulate neurotransmitter release and promote neurogenesis. While preclinical studies consistently demonstrate ...
7 days agoIn the medical field, welcome to acronyms.GLP-1stands for glucagon-like peptide-1, and this is a hormone in the body. When we talk aboutGLP-1sorGLP-1agonists as a medication, this means that these are manufactured substances that cause the same action in the body as the naturally occurring hormone would. Kristen Meinzer: And how doGLP-1s...
Mar 16, 2026This randomized clinical trial of US adults treated with stable doses of glucagon-like peptide-1and/or glucose-dependent insulinotropic polypeptide agonists examines the effects on residual gastric volume.
2 days agoIn recent years, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as promising agents for cardiovascular and cerebrovascular risk reduction in patients with T2DM.
BACKGROUND:GLP-1(glucagon-like peptide-1) receptor agonists and SGLT2 (sodium-glucose cotransporter 2) inhibitors both improve cardiovascular and kidney outcomes in people with type 2 diabetes. We conducted a systematic review and meta-analysis to assess the effects ofGLP-1receptor agonists on clinical outcomes with and without SGLT2 inhibitors.
TodayA recent study has linkedGLP-1use to a higher risk of bone conditions and gout.
Sep 19, 2025TheGLP-1boom is making people desperate to get the pricey weight-loss drugs. They won't get the real medication in "GLP-1patches," doctors warn.
Jul 1, 2025Learn how to naturally boost yourGLP-1levels to support weight loss, appetite control and blood sugar balance through diet and lifestyle habits.
We would like to show you a description here but the site won't allow us.
Sep 19, 2025GLP-1medications like Ozempic, Wegovy, Mounjaro, and Zepbound help control blood sugar and promote weight loss by reducing appetite and slowing digestion. They're typically prescribed for obesity or type 2 diabetes, with potential side effects. Discuss options with a WMCHealth specialist.
Mar 14, 2026Glutamateserves as a potent stimulator ofGLP-1. 223 A decrease in Ruminococcus abundance directly reduces the level ofglutamatein the intestine, thereby inhibiting the synthesis and secretion ofGLP-1.